P

Inventor

WADE MICHAEL

US36 patents
⚠️ This page may combine multiple inventors who share the name “WADE MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNITED THERAPEUTICS CORP

19 patents
US9199908B2Dec 1, 2015

Compounds and methods for delivery of prostacyclin analogs

UNITED THERAPEUTICS CORP46 citations97
US7879909B2Feb 1, 2011

Use of Treprostinil to treat neuropathic diabetic foot ulcers

UNITED THERAPEUTICS CORP63 citations96
US6756033B2Jun 29, 2004

Method for delivering benzindene prostaglandins by inhalation

UNITED THERAPEUTICS CORP124 citations96
US6521212B1Feb 18, 2003

Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

UNITED THERAPEUTICS CORP149 citations96
US7199157B2Apr 3, 2007

Use of treprostinil to improve kidney functions

UNITED THERAPEUTICS CORP120 citations95
US10080730B2Sep 25, 2018

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

UNITED THERAPEUTICS CORP23 citations94
US10071123B2Sep 11, 2018

Treatment of pulmonary arterial hypertension with mesenchymal stem cells

UNITED THERAPEUTICS CORP21 citations94
US10016463B2Jul 10, 2018

Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

UNITED THERAPEUTICS CORP19 citations94
US6054486AApr 25, 2000

Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease

UNITED THERAPEUTICS CORP121 citations94
US10076505B2Sep 18, 2018

Inhalation formulations of Treprostinil

UNITED THERAPEUTICS CORP14 citations92
US9713599B2Jul 25, 2017

Parenteral formulations of treprostinil

UNITED THERAPEUTICS CORP18 citations92
US11141393B2Oct 12, 2021

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

UNITED THERAPEUTICS CORP9 citations85
US10842823B2Nov 24, 2020

Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

UNITED THERAPEUTICS CORP8 citations84
US11839596B2Dec 12, 2023

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

UNITED THERAPEUTICS CORP3 citations73
US11839631B2Dec 12, 2023

Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

UNITED THERAPEUTICS CORP3 citations73
US10695308B2Jun 30, 2020

Inhalation formulations of treprostinil

UNITED THERAPEUTICS CORP2 citations73
US12310992B2May 27, 2025

Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

UNITED THERAPEUTICS CORP0 citations62
US12274684B2Apr 15, 2025

Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

UNITED THERAPEUTICS CORP0 citations62
US11666602B2Jun 6, 2023

Treatment of pulmonary arterial hypertension with mesenchymal stem cells

UNITED THERAPEUTICS CORP1 citations62

MESO SCALE TECHNOLOGIES LLC

7 patents

WADE MICHAEL

4 patents

US GOV SEC NAVY

4 patents

PLANET DATA SOLUTIONS

2 patents